More results...

logo_oncodesign_services_blanc_couleurs

More results...

  • Fr
  • En
Contact
  • Fr
  • En
  • Discovery Services
    • Structural Biology Services
    • Medicinal Chemistry
    • In Vitro biology
    • DMPK
    • Bioanalysis, Formulation, Immunogenicity and Biomarkers
    • Bioconjugation & Radiochemistry platform
    • In Vivo Pharmacology
    • In Vivo Imaging
  • Oncology
    • Immuno-oncology
    • Tumor Models
    • Orthotopic Models
    • Metastatic Models
    • Humanized Models
    • Single Mouse Preclinical Trial (SMPT)
    • Molecular RadioTherapy (MRT)
  • Inflammation
    • Autoimmunity models
    • Dermal models
    • Endometriosis models
    • Gut models
    • Kidney models
    • Liver models
    • Lung models
    • Systemic Inflammation Models
  • Infectious diseases
    • Covid-19
    • Arboviruses
    • Influenza A/H1N1
  • Microbiome
  • Resources
  • Join us!
    • Job offers
    • Our HR Policy
  • About us
    • Our history
    • Management
    • Our CSR approach
    • Network
    • News
Contact
  • EXPLORE: Identification and validation of therapeutic targets
  • DRIVE-IDDS: integrated drug discovery solution
  • INPACT: integrated services in preclinical pharmacology
  • SOLO: offers from our innovative technical platforms
  • D-VLOP: bringing your drug to IND filing
Home . Resources . Press coverage . Page 5

News

Press coverage

Ressources presse
11/03/2014

[FR] Capital – Oncodesign, une nouvelle biotech débarque sur Alternext

Read more
Ressources presse
11/03/2014

[FR] Traces écrites – Oncodesign lance aujourd’hui à Dijon son entrée en bourse sur le marché Alternext à Paris

Read more
Ressources presse
10/03/2014

[FR] Boursier – Oncodesign se lance en bourse

Read more
Ressources presse
14/02/2014

[FR] France 3 – La société Oncodesign lance son introduction en Bourse (vidéo)

Read more
Ressources presse
12/02/2014

[FR] France 3 Bourgogne – La société Oncodesign lance son introduction en Bourse

Read more
Ressources presse
11/02/2014

[FR] Le Bien Public – Les Dijonnais d’Oncodesign vont entrer en bourse

Read more
Ressources presse
10/02/2014

[FR] Tout sur mes Finances – Oncodesign, première IPO éligible au PEA PME ?

Read more
1 2 … 4 5

Contact-us

20 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260

Get in touch

Science within easy reach!

Receive our general news!

Explore Oncodesign Services vitality
logo_oncodesign_services_blanc_couleurs

Follow us

linkedin twitter Stand with Ukraine
  • Discovery Services
    • Medicinal Chemistry
    • In Vitro biology
    • DMPK
    • In Vivo Pharmacology
  • Therapeutic areas
    • Oncology
    • Inflammation
    • Infectious diseases
  • Integrated Solutions
    • Small Molecule
    • Molecular Radiotherapy
    • Biologics
  • Legal notice
  • Personal data policy
  • General Terms And Conditions Of Purchase
  • Contact